National Heart, Lung, and Blood Institute State of the Science Symposium in therapeutic apheresis - Therapeutic apheresis in cardiovascular disease

Jeffrey L. Winters, Leslie T Jr. Cooper, Nora R. Ratcliffe, Yanyun Wu, Patrick M. Moriarty

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

The National Heart, Lung, and Blood Institute in collaboration with the American Society for Apheresis, convened a State of the Science Symposium in November of 2012 due to the expanding application of therapeutic apheresis despite the lack of well-designed research to address its efficacy. This article reviews the opportunities that were presented at this meeting in the area of cardiovascular disease (CVD), specifically the use of columns to adsorb autoantibodies in dilated cardiomyopathy or damaging lipids in peripheral vascular disease. Understanding how absorption of these pathologic substances alters the inflammatory response in these disorders is important for the application of these technologies to the treatment of CVD.

Original languageEnglish (US)
Pages (from-to)183-187
Number of pages5
JournalJournal of Clinical Apheresis
Volume30
Issue number3
DOIs
StatePublished - Jun 1 2015

Keywords

  • Apheresis
  • Immunoadsorption
  • Lipid apheresis
  • Myocarditis
  • Peripheral vascular disease

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'National Heart, Lung, and Blood Institute State of the Science Symposium in therapeutic apheresis - Therapeutic apheresis in cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this